Özlem Özbağçıvan

Dr. Özlem Özbağçıvan


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2015 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
AGAli Tahsin Gunes
Ali Tahsin Gunes
EFEmel Fetil
Emel Fetil
SASevgi Akarsu
Sevgi Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
LBLale Babayeva
Lale Babayeva
Psoriasis is a chronic, recurrent, immune-mediated inflammatory disease and it can be provoked or exacerbated by a variety of different environmental factors, particularly infections and drugs. In addition, a possible association between vaccination and the new onset and/or exacerbation of psoriasis has been reported by a number of different authors. The aim of this study is to investigate the effects of influenza vaccination on patients with psoriasis. Here, we report the findings from 43 patients suffering from psoriasis (clinical phenotypes as mixed guttate/plaque lesions, palmoplantar or scalp psoriasis) whose diseases had been triggered after influenza vaccination applied in the 2009-2010 season. The short time intervals between vaccination and psoriasis flares in our patients and the lack of other possible triggers suggest that influenza vaccinations may have provocative effects on psoriasis. However, further large and controlled studies need to be carried out to confirm this relationship.

25 May 2019 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
SASevgi Akarsu
Sevgi Akarsu
FSFatma Semiz
Fatma Semiz
EFEmel Fetil
Emel Fetil

1 October 2018 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
SASevgi Akarsu
Sevgi Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
TITurna Ilknur
Turna Ilknur
FSFatma Semiz
Fatma Semiz
BIBurcu Bahar Inci
Burcu Bahar Inci
EFEmel Fetil
Emel Fetil
Keywords: Dermatitis, atopic; Female; Prurigo

1 January 2017 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
SASevgi Akarsu
Sevgi Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
NDNecla Dolaş
Necla Dolaş
SASebnem Aktan
Sebnem Aktan
The distribution and the demographic, etiological, and clinical features of autoimmune bullous diseases (ABDs) vary according to geographic regions of the world. The limited number of reported studies in Turkey are mostly retrospective and generally include only pemphigus. The aim of our study was to evaluate the demographic data, clinical features, associated triggering factors, and comorbidities in patients newly diagnosed with ABDs. In this descriptive and prospective study, the demographic data, inhabited regions, smoking and drinking habits, presence of comorbidities, and specific and general potential triggering factors of ABDs considered by the patients were examined. Furthermore, the distribution of lesions and autoimmune bullous skin disorder intensity scores were recorded. Of the total 59 ABD patients, 26 (44.1%) were diagnosed with pemphigus, 25 (42.4%) were diagnosed with pemphigoid, and 8 (13.5%) were diagnosed with dermatitis herpetiformis. Although there were some differences between the subgroups of ABDs, the onset of the disease was associated with a triggering factor (stress, foods, physical trauma, chemical agents, ultraviolet rays, medications, infections, malignancies, and pregnancy, in a decreasing frequency) in 96.6% of the patients. Autoimmune diseases, neuropsychiatric disorders, diabetes mellitus, and hypertension were found to be statistically significantly higher in the pemphigoid group compared to the pemphigus and dermatitis herpetiformis groups. Evaluation of triggering factors and comorbidities before starting treatment may assist in controlling the disease more swiftly and reducing the side effects of treatment in the management of ABDs. However, to evaluate the frequency and significance of our findings in order to determine whether they are statistically significant or not, we suggest a multicenter prospective clinical trial, which would include control groups and a higher number of patients for each of the disease groups and clinical subtypes.

3 January 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
SASevgi Akarsu
Sevgi Akarsu
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
FSFatma Semiz
Fatma Semiz
SASebnem Aktan
Sebnem Aktan
Although it is known that systemic form of lupus erythematosus (LE) and metabolic syndrome (MetS) are frequently observed together, there are no published reports on MetS in patients with skin-restricted LE. We aimed to compare the frequencies of MetS and its components in discoid LE (DLE) with the non-DLE control group. Additionally, we intended to determine the differences of sociodemographic and clinical data of the DLE patients with MetS compared to the patients without MetS. This was a cross-sectional, case-control study, including 60 patients with DLE and 82 age- and gender-matched control subjects. In DLE group, the presence of MetS was observed as more frequent (48.3% versus 24.4%, p=0.003), and hypertriglyceridemia (43.3% versus 22.0%, p=0.006) and reduced HDL-cholesterol (61.7% versus 23.2%, p<0.001) among the MetS components were found significantly higher when compared to the control group. DLE patients with MetS were at older age (50.45±11.49 versus 43.06±12.09, p=0.02), and hypertension, hyperlipidemia/dyslipidemia, and cardiovascular disease histories were observed at a higher ratio when compared to the patients without MetS. Between the DLE patients with and without MetS, no significant difference was observed in terms of clinical characteristics of DLE. Moreover, further large case-control studies with follow-up periods would be required to clearly assess the impact of MetS on the clinical outcomes of DLE.

28 May 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
ÖÖÖzlem Özbağçıvan
Özlem Özbağçıvan
SASevgi Akarsu
Sevgi Akarsu
CACeylan Avci
Ceylan Avci
BIBurcu Bahar Inci
Burcu Bahar Inci
EFEmel Fetil
Emel Fetil
Even though infections are the most common cause of erythema nodosum (EN), only certain microorganisms take the great interest such as streptococci in knowledge. Our aim was to examine the frequency and type of infections in EN, to determine the characteristics of patients with an infectious etiology, and to discuss the role of these microbes in EN pathology in the context of their interactions with humans. Charts of 81 patients with EN who were seen between 2003 and 2017 were retrospectively reviewed. Identified etiological factors were classified into three groups: infectious, noninfectious, and idiopathic. While there were no significant demographic and clinical differences between the infectious and idiopathic groups, systemic symptoms (p=0.034) and the number of EN lesions (p=0.016) were significantly lower; the mean erythrocyte sedimentation rate was significantly higher (p=0.049), but the mean aspartate aminotransferase value was significantly lower in the infectious group compared to the noninfectious group (p=0.019). Besides streptococci, many other microbes, including the ones living on and inside us, were identified in the etiology of EN. There is a need for large-scale prospective studies involving control groups for a better understanding of the microbial immunopathology of EN.